CICC, an investment banking firm, led a $150m Series B funding round in Singlera Genomics, a genetic diagnosis company. The round was joined by Detong Capital, Furong Investment, Huamei International, Linden, Wuxi Capital, FutureX Capital, Shanghai Free Trade Zone Fund, Greenpine Capital, Prosperico Ventures, and Proxima Ventures. "We thank investors for their trust and support. I am honored that the innovative R&D, clinical transformation, and commercialization capabilities of Singlera have been recognized by top investors. This round of financing will help us further expand our product system and strengthen our strategic advantages and marketing capabilities in the field of early tumor screening and liquid biopsy," Johny Zhang, Singlera Co-Founder and CEO.